Histogen (HSTO)
(Delayed Data from OTC)
$0.21 USD
0.00 (0.00%)
Updated Jul 10, 2024 01:04 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HSTO 0.21 0.00(0.00%)
Will HSTO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HSTO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HSTO
Histogen (HSTO) Upgraded to Strong Buy: Here's What You Should Know
HSTO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for HSTO
Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
Histogen files for Chapter 11, seeks liquidation
Histogen files for voluntary Chapter 11 protection